Question from Deputy Ken O'Flynn - PQ 36797-26
Deputy O'Flynn asked if the HSE records the number of rejected claims relating specifically to respiratory medications. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked if the HSE records the number of rejected claims relating specifically to respiratory medications. Read the HSE response.
Deputy O'Flynn asked about the protocol for assessing manganese exceedance notifications. Read the HSE response.
Deputy O'Flynn asked about reimbursement thresholds for applications under the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked about the reducing the number of rejected or unpaid pharmacy claims attributable to administrative or submission errors.
Deputy O'Flynn asked about the proportion of rejected pharmacy claims subsequently resubmitted successfully as corrected reclaims. Read the HSE response.
Deputy O'Flynn asked about the key performance indicators currently used within the Health Regions framework. Read the HSE response.
Deputy O'Flynn asked about the HSE Performance and Accountability Framework. Read the HSE response.
Deputy O'Flynn asked about the absence of SCAN services in the HSE Mid West area. Read the HSE response.
Deputy O'Flynn asked if comparative regional dashboards exist that show differences between the 6 health regions. Read the HSE response.
Deputy McGettigan asked about the procedures in place where concerns are raised that a clinician has recorded or shared inaccurate clinical information.